SIGNUM BIOSCIENCES

Company Information

Company Name
SIGNUM BIOSCIENCES
Address
7 DEER PARK DR, STE H
MONMOUTH JUNCTION, NJ, -
Phone
n/a
URL
n/a
DUNS
144196354
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,307,558.00
4
SBIR Phase II
$6,219,380.00
3
Chart code to be here

Award List

  1. A Novel Class of Therapeutic Agents for the Treatment of Skin Diseases Associated

    Amount: $356,919.00

    DESCRIPTION (provided by applicant): N-acetyl-S-famesyl-L-cysteine (AFC) and its derivatives (isoprenylcysteine (IPC) analogs) represent a novel class of topically absorbed NSAIDs whose activity is re ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. A Novel Class of Topical Pleitropic Anti-Acne Therapeutics

    Amount: $327,178.00

    DESCRIPTION (provided by applicant): Acne is a multifactorial disease affecting ~50 million people in the US. Three main factors contribute to the pathogenesis of acne; 1) P. acnes growth 2) P. ac ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Phosphoprotein phosphatase 2A, a new target for Alzheimer's Disease interventio

    Amount: $324,717.00

    DESCRIPTION (provided by applicant): Abnormal hyperphosphorylation of tau plays an important role in Alzheimer's disease (AD) and other tauopathies. Current therapeutic approaches with focus on tau ki ...

    SBIR Phase I 2010 Department of Health and Human Services
  4. A Novel Class of Non Steroidal Anti-Inflammatories

    Amount: $298,744.00

    DESCRIPTION (provided by applicant): Isoprenylcysteine (IPC) analogs, such as N-acetyl-S-farnesyl-L-cysteine (AFC) modulate heterotrimeric G- protein and Ras-related signaling pathways, representing ...

    SBIR Phase I 2008 Department of Health and Human Services
  5. A Topical Non Steroidal Anti-inflammatory for Rosacea

    Amount: $1,568,458.00

    DESCRIPTION (provided by applicant): Isoprenylcysteine (IPC) analogs modulate heterotrimeric G-protein coupled receptor (GPCR) signaling pathways, representing a novel class of topical anti-inflammato ...

    SBIR Phase II 2009 Department of Health and Human Services
  6. A Topical Non Steroidal Anti-inflammatory for Rosacea

    Amount: $2,975,892.00

    DESCRIPTION (provided by applicant): Rosacea is a chronic dermatological condition characterized by flushing, erythema, papules, pustules, inflammatory nodules and telangiectasia. Although disease eti ...

    SBIR Phase II 2011 Department of Health and Human Services
  7. A Topical Non-steroidal Anti-inflammatory for Atopic Dermatitis

    Amount: $1,675,030.00

    DESCRIPTION (provided by applicant): Atopic dermatitis is a chronic dermatological condition afflicting mostly infants and young children. Current treatments are associated with a wide range of side e ...

    SBIR Phase II 2013 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government